ReGEN Biomedical specializes in growing substantial quantities of resilient and consistent small tissue fragments, known as micro-tissues, which can be used for toxicity and pharmaceutical screening. These functional micro-tissues mark a significant advancement in replicating patient organs and signify the future of personalized medicine.

Their focus extends to developing proficiency in assembling these micro-tissues into functional segments of human organs, referred to as macro-tissues. Additionally, these micro-tissues serve as foundational components for Regenerative Medicine (RM) therapies, where they are integrated to form functional macro-tissues.

Their goal is to fully automate all production platforms and integrate advanced offline and inline quality control systems to ensure precision and efficiency in the manufacturing process.

Interesting for all bachelor and master students!